CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 17 enrolled
Drug / intervention
Prednisone +1 moredrug
Likely dose
Prednisone 1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00271791
NCT00271791Phase 2Completed
CompareCT.gov

Prednisone Treatment for Vestibular Neuronitis

Carmel Medical Center·interventional·Posted Jan 4, 2006·Updated Nov 6, 2007

In Brief

A Phase 2 clinical trial evaluating Prednisone for Vestibular Diseases and Vestibular Neuronitis. Completed, enrolled 17 participants across 4 sites.

Detailed Summary

The purpose of the study is to investigate the value of steroids in the treatment of vestibular neuronitis. The potential benefits of steroid therapy would be analyzed by the clinical response, self-perceived handicap and laboratory parameters.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVestibular Diseases, Vestibular Neuronitis
CountriesIsrael
CollaboratorsClalit Health Services, Haifa and West Galilee, Hillel Yaffe Medical Center, Rambam Health Care Campus, University Health Network, Toronto

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 4, 2006
Enrollment StartSep 1, 2005
Study CompletionMay 1, 2007
TodayJul 2, 2026
Posted 20.5 years ago

Interventions

Prednisonedrug

PO, 1 mg/kg body weight, 5 days Short tapering regimen: daily reductions in the dose, 12 days

Prednisonedrug

PO, Placebo, 17 days